Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 9,146,561 | 9,428,640 | 9,904,908 | 9,372,767 | 8,924,911 |
| Cost of Goods | 3,112,853 | 3,117,193 | 3,316,083 | 3,047,728 | 3,056,162 |
| Gross Profit | 6,033,708 | 6,311,446 | 6,588,826 | 6,325,039 | 5,868,749 |
| Operating Expenses | 3,906,474 | 5,572,113 | 4,709,576 | 6,542,438 | 4,832,997 |
| Operating Income | 2,128,087 | 739,526 | 1,879,332 | -216,670 | 1,035,914 |
| Interest Expense | 240,308 | 215,022 | 235,081 | 262,587 | 259,337 |
| Other Income | 32,206 | 1,243 | 28,893 | 22,958 | 25,791 |
| Pre-tax Income | 1,919,985 | 525,747 | 1,673,144 | -456,298 | 802,368 |
| Income Tax | 405,055 | 131,747 | 510,874 | 249,673 | 298,022 |
| Net Income Continuous | 1,514,930 | 393,999 | 1,162,271 | -705,971 | 504,346 |
| Minority Interests | 219,250 | 74,574 | 101,124 | -81,789 | 100,296 |
| Net Income | $1,295,680 | $319,425 | $1,061,146 | $-624,182 | $404,050 |
| EPS Basic Total Ops | 0.66 | 0.17 | 0.55 | -0.32 | 0.21 |
| EPS Basic Continuous Ops | 0.78 | 0.20 | 0.60 | -0.36 | 0.26 |
| EPS Diluted Total Ops | 0.66 | 0.17 | 0.54 | -0.32 | 0.21 |
| EPS Diluted Continuous Ops | 0.77 | 0.20 | 0.59 | -0.36 | 0.26 |
| EBITDA(a) | $2,531,903 | $N/A | $2,013,558 | $359,896 | $1,835,417 |